DBV Technologies (DBVT) Change in Receivables (2020 - 2021)

DBV Technologies (DBVT) posted Change in Receivables of $24000.0 for Q4 2021, up 2300.0% sequentially from $1000.0 in Q3 2021, and down 75.0% YoY from $96000.0 in Q4 2020.

DBV Technologies (DBVT) Change in Receivables (2020 - 2021) Analysis & Trends

DBV Technologies has reported Change in Receivables for 2 years, with the latest figure at $24000.0 in Q4 2021.

  • Quarterly Change in Receivables fell 75.0% year-over-year to $24000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $24000.0 (up 101.15% YoY) and the FY2021 annual result came in at -$2.2 million, down 203.86% from the prior year.
  • Change in Receivables grew to $24000.0 in Q4 2021 per DBVT's latest filing, from $1000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $2.0 million in Q3 2020 and troughed at -$2.1 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 117.58 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -483,662.49
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 31.60 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 37.16 Mn
10 DBV Technologies 6.08 Bn 5.90 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 24,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 1,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 -74,000.00
Jun 30, 2021 -74,000.00
Mar 31, 2021 -2.10 Mn
Mar 31, 2021 -2.10 Mn
Dec 31, 2020 96,000.00
Dec 31, 2020 96,000.00
Sep 30, 2020 1.98 Mn
Sep 30, 2020 1.98 Mn